Quick Listen: Scrip’s Five Must-Know Things
Take a brief audio tour around the main biopharma industry events of the past week, as brought to you by Scrip's global team, in this podcast version of Five Must-Know Things.
Join us in our regular podcast on major industry events in this audio version of Scrip's Five Must-Know Things, this time for the business week ended 6 November 2020.
No surprises that the US presidential election features this week, along with a major oncology acquisition, use of AI in the hunt for COVID drugs, progress in atopic dermatitis, and the opportunity for pharma to rebuild its reputation amid the pandemic.
These and other Informa Pharma Intelligence podcasts are available on SoundCloud, Apple Podcasts and TuneIn, and also via Alexa smart speakers.
(Also see "President ????: What US Election Uncertainty Means For Biopharma" - Scrip, 4 Nov, 2020.)
(Also see "Sanofi Bids €308m To Buy Kiadis" - Scrip, 2 Nov, 2020.)
(Also see "AI Can Find Many Drugs To Repurpose For COVID-19, But Real-World Results Mixed" - Scrip, 4 Nov, 2020.)
(Also see "Positive Atopic Dermatitis Data On Lilly's Newly-Approved Olumiant" - Scrip, 2 Nov, 2020.)
(Also see "Can Pharma Rebuild Its Reputation? COVID-19 Means A Big Responsibility, And Opportunity" - Scrip, 30 Oct, 2020.)